Are adverse events following an invasive strategy in patients with non-ST-segment elevation acute coronary syndromes more frequent at US sites versus Non-US sites? analysis from the ACUITY trial
- Patrick Tobbia
- , Bruce R. Brodie
- , Thomas Stuckey
- , Brent T. McLaurin
- , David A. Cox
- , Martin Fahy
- , Ke Xu
- , Roxana Mehran
- , Gregg W. Stone
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations